Praziquantel transdermal preparation and applications thereof

The technology of a transdermal preparation and praziquantel is applied in the field of praziquantel, which can solve the problems of inconvenient administration, low drug utilization rate, pain in livestock and the like, and achieves the effects of convenient administration, no toxic side effects and remarkable curative effect.

Inactive Publication Date: 2011-08-03
SHANGHAI VETERINARY RES INST CHINESE ACAD OF AGRI SCI
1 Cites 3 Cited by

AI-Extracted Technical Summary

Problems solved by technology

At present, veterinary praziquantel preparations are still tablets and powders, which have the disadvantages of poor absorption and severe first-pass effect of the liver, resulting in low drug utilization and large side effects. Ketones tend to...
View more

Method used

Preferably, praziquantel transdermal preparation also comprises the transdermal penetration enhancer of 0.1~5% by weight, and this transdermal penetration enhancer is selected from linoleoyl polyisoglycol glyceride, isomyristate One or a combination of any two or more of propyl ester, azone, propylene glycol, N-methyl-pyrrolidone, oleic acid or peppermint oil. Adding a transdermal penetration enhancer with a penetratio...
View more

Abstract

The invention discloses a praziquantel transdermal preparation prepared from the following components in percentage by weight: 8-35 percent of praziquantel, 40-60 percent of 206 adjuvant and 5-45 percent of aqueous solution or purified water. The invention also discloses applications of the praziquantel transdermal preparation. The praziquantel transdermal preparation provided by the invention not only is convenient to administrate, but also has the same effects on treating and blocking schistosomiasis from being propagated as an oral preparation.

Application Domain

Organic active ingredientsPharmaceutical delivery mechanism +3

Technology Topic

AdjuvantAqueous solution +3

Image

  • Praziquantel transdermal preparation and applications thereof
  • Praziquantel transdermal preparation and applications thereof
  • Praziquantel transdermal preparation and applications thereof

Examples

  • Experimental program(6)
  • Effect test(1)

Example Embodiment

[0024] The preparation method of praziquantel transdermal preparation of the present invention comprises the following steps:
[0025] Heat an appropriate amount of 206 adjuvant, aqueous solution or purified water to 28°C-32°C respectively;
[0026] Mix the preheated 206 adjuvant and praziquantel, add preheated aqueous solution or purified water and mix evenly until the praziquantel transdermal preparation is obtained.

Example Embodiment

[0028] Example 1
[0029] (1) Measure 54ml of 206 adjuvant; prepare 38.32ml of sterilized PBS (PH8.0); heat the above solvent to 30°C±2°C;
[0030] (2) Weigh 7.68g of praziquantel, pour it into a sterile beaker, and preheat to 30°C±2°C;
[0031] (3) Add 54ml of preheated 206 adjuvant into the beaker;
[0032] (4) Place the rotor of the FJ-200 high-speed dispersing homogenizer in a beaker containing praziquantel and 206 adjuvants;
[0033] (5) Start stirring at a low speed (200-300 rpm) and gradually add 38.32ml of preheated PBS, the flow rate of PBS is 5-10 liters/min;
[0034] (6) Accelerate to 2000 rpm and keep it for 10 minutes;
[0035] (7) Stop stirring to obtain the praziquantel transdermal preparation containing 8% (weight percentage) praziquantel, wherein the weight percentage of 206 adjuvant is 50%, and the volume percentage is 54%; At low temperature (4 ℃ ~ 12 ℃).

Example Embodiment

[0036] Example 2
[0037] (1) Measure 43.2ml of 206 adjuvant; prepare 33.6ml of sterilized saline; heat the above solvent to 30°C±2°C;
[0038] (2) Weigh 23.2g of praziquantel, pour it into a sterile beaker, and preheat to 30°C±2°C;
[0039] (3) Add 43.2ml of preheated 206 adjuvant into the beaker;
[0040] (4) Place the rotor of the FJ-200 high-speed dispersing homogenizer in a beaker containing praziquantel and 206 adjuvants;
[0041] (5) Start stirring at a low speed (200-300 rpm) and gradually add 33.6ml of preheated saline, the flow rate of which is 5-10 liters/min;
[0042] (6) Accelerate to 2000 rpm and keep it for 10 minutes;
[0043] (7) Stop stirring to obtain the praziquantel transdermal preparation containing 24% (weight percentage) praziquantel, wherein the weight percentage of 206 adjuvant is 40%, and the volume percentage is 43.2%; At low temperature (4 ℃ ~ 12 ℃).

PUM

no PUM

Description & Claims & Application Information

We can also present the details of the Description, Claims and Application information to help users get a comprehensive understanding of the technical details of the patent, such as background art, summary of invention, brief description of drawings, description of embodiments, and other original content. On the other hand, users can also determine the specific scope of protection of the technology through the list of claims; as well as understand the changes in the life cycle of the technology with the presentation of the patent timeline. Login to view more.

Similar technology patents

Meptazinol hydrochloride nasal spray and preparation method thereof

ActiveCN107260673AImprove drug bioavailabilityEasy to administer
Owner:YANGTZE RIVER PHARM GRP SICHUAN HAIRONG PHARM CO LTD +1

Drug composition for elaphe carinata pneumonia and preparation method thereof

InactiveCN109106791AImprove feeding enthusiasmEasy to administer
Owner:三江县连兴科技有限公司

Traditional Chinese medicine drug for treating hepatitis

InactiveCN109674984ACompatibility is reasonableEasy to administer
Owner:ZIBO MINGTONG ENVIRONMENTAL TECH RES & DEV CO LTD

Classification and recommendation of technical efficacy words

  • Significant effect
  • Easy to administer

'Huajuhong' preparation and its preparing process

InactiveCN1369306AEasy to administerreduce dosage
Owner:化州化橘红药材发展有限公司

Capsule for treating headache and method for preparing the same

ActiveCN101194959AEasy to administergood for headaches
Owner:TIANJIN TASLY PHARMA CO LTD

Ceftiofur hydrochloride breast injection for dairy cow in dry period and preparation method thereof

ActiveCN104546704ASignificant effectEasy to administer
Owner:FEED RESEARCH INSTITUTE CHINESE ACADEMY OF AGRICULTURAL SCIENCES

Medicament for curing leukemia

InactiveCN101837058Ashort course of treatmentEasy to administer
Owner:郭完祥

Intelligent medicine box

PendingCN110668078AEasy to administerImprove the effect of treatment
Owner:THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products